Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 253

Cover covets corporates in $16m series B

Exor and Samsung Ventures both chipped in as the mobile insurance brokerage boosted its overall funding to $27m.

Oct 3, 2018

Mumzworld takes care with $20m round

Tamer and Twofour54-backed Mumzworld plans to use Gulf Islamic Investments' series B funding to expand its e-commerce platform in Saudi Arabia.

Oct 3, 2018

Human Inc heads to $21m series B

Microsoft has invested in consumer technology developer Human, Incorporated's series B round, which was co-led by Sage Venture Partners, Ropart Asset Management and Sugar Mountain Capital.

Oct 3, 2018

Pivot Bio reaps $70m in series B funding

Monsanto-backed Pivot Bio has now raised a total of almost $87m and will use the latest funding to develop its second crop nutrition product.

Oct 3, 2018

M12 drives Netradyne's series B to $21m

Reliance Industries returned to invest $8m in an M12-led round that took Netradyne's funding to $37m in just over two years.

Oct 3, 2018

Shopal shuts series B-plus round

The luxury branding services provider raised $29.2m in a round led by Youngor Group that included existing investor Cathay Capital Private Equity.

Oct 2, 2018

Pymetrics picks out corporates to raise $40m

Recruitment analytics technology provider Pymetrics has closed a series B round featuring Salesforce Ventures and returning investor Workday Ventures.

Oct 2, 2018

Gilmour Space thrusts $13.7m into orbit

Satellite launching rocket producer Gilmour Space Technologies has been backed by Main Sequence Ventures, managers of Csiro Innovation Fund, taking its total to $17.4m.

Oct 1, 2018

Corporate venturing deal net: 24-28 September 2018

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sep 28, 2018

Morphic shapes $80m series B

Novo has co-led a series B round together with Omega Funds for Morphic Therapeutic, based on research by Harvard professor Timothy Springer.

Sep 28, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here